Who will acquire 23andMe?
➕
Plus
54
Ṁ6431
Dec 31
88%
Anne Wojcicki
22%
Regeneron
12%
Hypera Pharma
11%
Roche
9%
Merck
9%
Johnson & Johnson
9%
Novartis
6%
Pfizer
5%
Eli Lilly
5%
Elon Musk

  • Update 2025-07-03 (PST) (AI summary of creator comment): In the event that 23andMe's assets are acquired by TTAM Research Institute, the market will resolve to Anne Wojcicki.

Get
Ṁ1,000
and
S3.00
Sort by:
bought Ṁ150 YES

On June 27, 2025, the U.S. Bankruptcy Court for the Eastern District of Missouri approved the proposed purchase of all of the assets of 23andMe by TTAM Research Institute (“TTAM”), and we anticipate that the sale will close on or as soon as reasonably practicable after July 8, 2025.


TTAM is a nonprofit medical research organization founded by Anne Wojcicki (Co-Founder and former CEO of 23andMe).

@Sketchy If this goes through, would this market resolve to Anne or TTAM?

@Sketchy Anne (?)

How about taken private?

Question suggestion: If 23andMe is acquired/purchased and the price is disclosed, what will be the price? (I'd create the question myself, but not sure what wording is most appropriate, so I'll let someone else create it.)

DiCaprio will mistakenly think it’s a dating site that matches his age interest.

sold Ṁ20 NO

I think this market should've been created in a way where they always add up to 100%.

@PaintspotInfez No, because they are not mutually exclusive. A deal where eg Eli Lily and Pfizer cooperate to keep 23&me alive is possible

Why not GSK?

@Athena You can add it

© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules